{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:19Z","timestamp":1792757179221,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/200043"],"award-info":[{"award-number":["451-03-9\/2021-14\/200043"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cyto.2021.155637","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T01:48:18Z","timestamp":1625276898000},"page":"155637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Between immunomodulation and immunotolerance: The role of IFN\u03b3 in SARS-CoV-2 disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Nata\u0161a","family":"Todorovi\u0107-Rakovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155637_b0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.149.3681.310","article-title":"Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin","volume":"149","author":"Wheelock","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.cyto.2021.155637_b0010","doi-asserted-by":"crossref","unstructured":"A. Billiau, P. Matthys P, Interferon-gamma: a historical perspective, Cytokine. Growth. Factor. Rev. 20(2009) 97\u2013113. http:\/\/dx.doi.10.1016\/j.cytogfr.2009.02.004.","DOI":"10.1016\/j.cytogfr.2009.02.004"},{"issue":"4","key":"10.1016\/j.cyto.2021.155637_b0015","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.1102879","article-title":"Diverse functions of distal regulatory elements at the IFNG locus","volume":"188","author":"Collins","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-\u03b3: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol"},{"key":"10.1016\/j.cyto.2021.155637_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/426479","article-title":"Literature-based discovery of IFN-gamma and vaccine-mediated gene interaction networks","volume":"2010","author":"Ozg\u00fcr","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.cyto.2021.155637_b0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155637_b0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The Interferon-Gamma Paradox in Cancer","volume":"39","author":"Zaidi","year":"2019","journal-title":"J. Interferon. Cytokine. Res."},{"key":"10.1016\/j.cyto.2021.155637_b0040","doi-asserted-by":"crossref","unstructured":"A.J. Lee, A.A. Ashkar, The Dual Nature of Type I and Type II Interferon, Front. Immunol. 9 (2018) 2061. http:\/\/dx.doi.10.3389\/fimmu.2018.02061.","DOI":"10.3389\/fimmu.2018.02061"},{"key":"10.1016\/j.cyto.2021.155637_b0045","doi-asserted-by":"crossref","unstructured":"Z. Zha, F. Bucher, A. Nejatfard, T. Zheng, H. Zhang, K.Yea et al. Interferon-\u03b3 is a master checkpoint regulator of cytokine-induced differentiation, Proc. Natl. Acad. Sci. U S A. 114(33) (2017) E6867\u2013E6874. http:\/\/dx.doi.10.1073\/pnas.1706915114.","DOI":"10.1073\/pnas.1706915114"},{"issue":"2","key":"10.1016\/j.cyto.2021.155637_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2009.02.006","article-title":"Structural conservation of interferon gamma among vertebrates","volume":"20","author":"Savan","year":"2009","journal-title":"Cytokine. Growth. Factor. Rev."},{"key":"10.1016\/j.cyto.2021.155637_b0055","doi-asserted-by":"crossref","unstructured":"Z.T. Qi, P. Nie, Comparative study and expression analysis of the interferon gamma gene locus cytokines in Xenopus tropicalis, Immunogenetics 60(699) (2008). https:\/\/doi.org\/10.1007\/s00251-008-0326-y.","DOI":"10.1007\/s00251-008-0326-y"},{"issue":"8","key":"10.1016\/j.cyto.2021.155637_b0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/1079990041689665","article-title":"Induction and regulation of IFNs during viral infections","volume":"24","author":"Malmgaard","year":"2004","journal-title":"J. Interferon. Cytokine. Res."},{"issue":"11","key":"10.1016\/j.cyto.2021.155637_b0065","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1099\/jgv.0.000613","article-title":"Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis","volume":"97","author":"Baxter","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155637_b0070","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.72.6.4547-4551.1998","article-title":"Does nitric oxide play a critical role in viral infections?","volume":"72","author":"Reiss","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2021.155637_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/2277-9175.102973","article-title":"The effect of interferon \u03b3 on endothelial cell nitric oxide production and apoptosis","volume":"1","author":"Javanmard","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.cyto.2021.155637_b0080","doi-asserted-by":"crossref","unstructured":"T. Hor-Yue, W. Ning, L. Sha, H. Ming, W. Xuanbin, F. Yibin, 2016 The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases, Oxidative Medicine and Cellular Longevity, 2016, Article ID 2795090, https:\/\/doi.org\/10.1155\/2016\/2795090.","DOI":"10.1155\/2016\/2795090"},{"key":"10.1016\/j.cyto.2021.155637_b0085","doi-asserted-by":"crossref","unstructured":"C. Atri, F.Z. Guerfali, D. Laouini, Role of Human Macrophage Polarization in Inflammation during Infectious Diseases, Int. J. Mol. Sci. 19(6) (2018) 1801. http:\/\/dx.doi.10.3390\/ijms19061801.","DOI":"10.3390\/ijms19061801"},{"key":"10.1016\/j.cyto.2021.155637_b0090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155637_b0095","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","article-title":"IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b","volume":"193","author":"Wu","year":"2014","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155637_b0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signaling, epigenetics, and roles in immunity, metabolism, disease, and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0105","doi-asserted-by":"crossref","unstructured":"H. Borges da Silva, R. Fonseca, J.M. Alvarez, M.R. D'Imp\u00e9rio Lima, IFN-\u03b3 Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases, J. Immunol. Res. 2015 (2015) 202816. http:\/\/dx.doi.10.1155\/2015\/202816.","DOI":"10.1155\/2015\/202816"},{"key":"10.1016\/j.cyto.2021.155637_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","article-title":"The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion","volume":"12","author":"Levy","year":"2001","journal-title":"Cytokine. Growth. Factor. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2021.155637_b0115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/vim.2004.17.498","article-title":"Inverse interference: how viruses fight the interferon system","volume":"17","author":"Weber","year":"2004","journal-title":"Viral. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0120","first-page":"73","article-title":"The interferon response circuit in antiviral host defense","volume":"71","author":"Haller","year":"2009","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"10.1016\/j.cyto.2021.155637_b0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2021.155637_b0130","article-title":"The role of cytokines in the evolution of cancer: IFN-\u03b3 paradigm","author":"Todorovi\u0107-Rakovi\u0107","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155637_b0135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cyto.2021.155637_b0140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.immuni.2018.05.016","article-title":"Holy Immune Tolerance, Batman!","volume":"48","author":"Randolph","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2021.155637_b0145","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2018.03.070","article-title":"The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity","volume":"173","author":"Pavlovich","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155637_b0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cyto.2021.155637_b0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/emph\/eoaa036","article-title":"Evolutionary medical insights into the SARS-CoV-2 pandemic","volume":"2020","author":"Crespi","year":"2020","journal-title":"Evol. Med. Public. Health."},{"key":"10.1016\/j.cyto.2021.155637_b0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cytogfr.2018.04.001","article-title":"The tolerogenic role of IFN-\u03b3","volume":"41","author":"Ro\u017eman","year":"2018","journal-title":"Cytokine. Growth. Factor. Rev."},{"key":"10.1016\/j.cyto.2021.155637_b0165","doi-asserted-by":"crossref","unstructured":"G.L. Kaj\u00e1n, A. Doszpoly, Z.L.Tarj\u00e1n et al. Virus\u2013Host Coevolution with a Focus on Animal and Human DNA Viruses, J. Mol. Evol. 88(2020)41\u201356 https:\/\/doi.org\/10.1007\/s00239-019-09913-4.","DOI":"10.1007\/s00239-019-09913-4"},{"key":"10.1016\/j.cyto.2021.155637_b0170","doi-asserted-by":"crossref","unstructured":"R.N. Jr McLaughlin, H.S. Malik, Genetic conflicts: the usual suspects and beyond, J. Exp. Biol. 220 (2017) 6\u201317. http:\/\/dx.doi.10.1242\/jeb.148148.","DOI":"10.1242\/jeb.148148"},{"key":"10.1016\/j.cyto.2021.155637_b0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic Variants of SARS-CoV-2\u2014What Do They Mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.cyto.2021.155637_b0180","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1128\/JVI.01636-14","article-title":"Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom","volume":"88","author":"Elderfield","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2021.155637_b0185","doi-asserted-by":"crossref","unstructured":"R. Maty\u00e1\u0161ek, A. Kova\u0159\u00edk, Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts, Genes(Basel). 11 (2020) 761. http:\/\/dx.doi.10.3390\/genes11070761.","DOI":"10.3390\/genes11070761"},{"key":"10.1016\/j.cyto.2021.155637_b0190","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s13238-017-0503-6","article-title":"IFN-\u03bb: A new spotlight in innate immunity against influenza virus infection","volume":"9","author":"Sun","year":"2018","journal-title":"Protein. Cell."},{"key":"10.1016\/j.cyto.2021.155637_b0195","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.188.8.1541","article-title":"Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice","volume":"188","author":"Karupiah","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2021.155637_b0200","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JVI.74.9.3996-4003.2000","article-title":"The role of alpha\/beta and gamma interferons in development of immunity to influenza A virus in mice","volume":"74","author":"Price","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2021.155637_b0205","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/eji.200737045","article-title":"Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak\/Stat pathway","volume":"38","author":"Uetani","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"18","key":"10.1016\/j.cyto.2021.155637_b0210","first-page":"30438","article-title":"Anti-IFN-\u03b3 therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice","volume":"S1684\u20131182","author":"Liu","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cyto.2021.155637_b0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2018.10.017","article-title":"Lack of IFN\u03b3 signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis","volume":"526","author":"Nicol","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2021.155637_b0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/mi.2017.41","article-title":"IFN-\u03b3 increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells","volume":"11","author":"Califano","year":"2018","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/jir.2009.0084","article-title":"IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner","volume":"30","author":"Weiss","year":"2010","journal-title":"J. Interferon. Cytokine. Res."},{"key":"10.1016\/j.cyto.2021.155637_b0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/CVI.00357-07","article-title":"Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus","volume":"15","author":"Long","year":"2008","journal-title":"Clin. Vaccine. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2020.10.045","article-title":"Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2","volume":"538","author":"Zinzula","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2021.155637_b0245","doi-asserted-by":"crossref","unstructured":"X. Lin, B. Fu, S. Yin, et al., ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating the IL-17 pathway, iScience. 24 (2021) 102293. http:\/\/dx.doi.10.1016\/j.isci.2021.102293.","DOI":"10.1016\/j.isci.2021.102293"},{"key":"10.1016\/j.cyto.2021.155637_b0250","doi-asserted-by":"crossref","unstructured":"R.K. Suryawanshi, R. Koganti, A. Agelidis, C.D. Patil, D. Shukla D, Dysregulation of Cell Signaling by SARS-CoV-2, Trends. Microbiol. 29 (2021) 224\u2013237. http:\/\/dx.doi.10.1016\/j.tim.2020.12.007.","DOI":"10.1016\/j.tim.2020.12.007"},{"key":"10.1016\/j.cyto.2021.155637_b0255","doi-asserted-by":"crossref","unstructured":"M. Has\u00f6ks\u00fcz, S. Kili\u00e7, F. Sara\u00e7, Coronaviruses and SARS-COV-2, Turk. J. Med. Sci. 50(SI-1) (2020) 549\u2013556. http:\/\/dx.doi.10.3906\/sag-2004-127.","DOI":"10.3906\/sag-2004-127"},{"key":"10.1016\/j.cyto.2021.155637_b0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.cyto.2021.155637_b0265","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-020-01486-5","article-title":"Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases","volume":"48","author":"Rossi","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.cyto.2021.155637_b0270","doi-asserted-by":"crossref","unstructured":"B. Jr Sainz , E.C. Mossel, C.J. Peters, R.F. Garry, Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV), Virology. 329 (2004) 11\u201317. http:\/\/dx.doi.10.1016\/j.virol.2004.08.011.","DOI":"10.1016\/j.virol.2004.08.011"},{"key":"10.1016\/j.cyto.2021.155637_b0275","doi-asserted-by":"crossref","unstructured":"R. Karki, B.R. Sharma, S.Tuladhar, E.P. Williams, L. Zalduondo, P. Samir, M. Zheng et al. Synergism of TNF-\u03b1 and IFN-\u03b3 Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes, Cell. 184 (2021) 149\u2013168. e17. http:\/\/dx.doi.10.1016\/j.cell.2020.11.025.","DOI":"10.1016\/j.cell.2020.11.025"},{"key":"10.1016\/j.cyto.2021.155637_b0280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2006.06.011","article-title":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells","volume":"353","author":"de Lang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2021.155637_b0285","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155637_b0290","doi-asserted-by":"crossref","unstructured":"I. Busnadiego, S. Fernbach, M.O. Pohl, U. Karakus, M. Huber, A. Trkola, et al., Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2, mBio. 11 (2020) e01928-20. http:\/\/dx.doi.10.1128\/mBio.01928-20.","DOI":"10.1128\/mBio.01928-20"},{"key":"10.1016\/j.cyto.2021.155637_b0295","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1167\/iovs.02-1106","article-title":"The critical role of IFN-gamma in experimental coronavirus retinopathy","volume":"44","author":"Hooks","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cyto.2021.155637_b0300","doi-asserted-by":"crossref","unstructured":"F. P\u00e9rez-Bartolom\u00e9, J. S\u00e1nchez-Quir\u00f3s, Ocular manifestations of SARS-CoV-2: Literature review. Manifestaciones oftalmol\u00f3gicas del SARS-CoV-2: Revisi\u00f3n de la literature, Arch. Soc. Esp. Oftalmol. 96 (2021) 32\u201340. http:\/\/dx.doi.10.1016\/j.oftal.2020.07.020.","DOI":"10.1016\/j.oftal.2020.07.020"},{"key":"10.1016\/j.cyto.2021.155637_b0305","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2021.155637_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585647","article-title":"Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients","volume":"11","author":"Hu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2021.155637_b0315","doi-asserted-by":"crossref","unstructured":"I.I. Esquivel-Moynelo, J. P\u00e9rez-Escribano, Y. Duncan-Roberts, D.D. Vazquez-Blonquist, M. Bequet-Romero, L. Baez-Rodr\u00edguez, J. Castro-R\u00edos, et al., Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA, medRxiv (2020). https:\/\/doi.org\/10.1101\/2020.07.29.20164251.","DOI":"10.1101\/2020.07.29.20164251"},{"key":"10.1016\/j.cyto.2021.155637_b0320","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.cyto.2021.155637_b0325","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2021.155637_b0330","doi-asserted-by":"crossref","unstructured":"M.C. Montalvo Villalba, O. Vald\u00e9s Ram\u00edrez, M. Mun\u00e9 Jim\u00e9nez, et al., Interferon gamma, TGF-\u03b21 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients, Clin. Immunol. 220 (2020) 108576. http:\/\/dx.doi.10.1016\/j.clim.2020.108576.","DOI":"10.1016\/j.clim.2020.108576"},{"key":"10.1016\/j.cyto.2021.155637_b0335","doi-asserted-by":"crossref","unstructured":"A.C. Gadotti, M. de Castro Deus, J.P. Telles, et al., IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection, Virus. Res. 289 (2020) 198171. http:\/\/dx.doi.10.1016\/j.virusres.2020.198171.","DOI":"10.1016\/j.virusres.2020.198171"},{"key":"10.1016\/j.cyto.2021.155637_b0340","first-page":"333","article-title":"Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19","volume":"2","author":"Yang","year":"2020","journal-title":"J. Cell. Immunol."},{"key":"10.1016\/j.cyto.2021.155637_b0345","doi-asserted-by":"crossref","unstructured":"N. Le Bert, H.E. Clapham, A.T. Tan, W.N. Chia, C.Y.L. Tham, J.M. Lim, K. Kunasegaran, et al., Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection, J. Exp. Med. 218 (2021) e20202617. http:\/\/dx.doi.10.1084\/jem.20202617.","DOI":"10.1084\/jem.20202617"},{"key":"10.1016\/j.cyto.2021.155637_b0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12250-020-00308-0","article-title":"Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility","volume":"35","author":"Wang","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.cyto.2021.155637_b0355","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-6-82","article-title":"The interferon gamma gene polymorphism +874 A\/T is associated with severe acute respiratory syndrome","volume":"6","author":"Chong","year":"2006","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155637_b0360","doi-asserted-by":"crossref","unstructured":"M Hayn, M. Hirschenberger, L. Koepke, J.H. Straub, R. Nchioua, M.H. Christensen, S. Klute et al. Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-\u03b3 and \u2013\u03bb, bioRxiv (2020). https:\/\/doi.org\/10.1101\/2020.10.15.340612.","DOI":"10.1101\/2020.10.15.340612"},{"key":"10.1016\/j.cyto.2021.155637_b0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","article-title":"Clinical Use of Interferon-gamma","volume":"1182","author":"Miller","year":"2009","journal-title":"Ann. N Y. Acad. Sci."},{"key":"10.1016\/j.cyto.2021.155637_b0370","doi-asserted-by":"crossref","first-page":"S456","DOI":"10.1007\/BF01743724","article-title":"Current and future clinical applications of interferon-gamma in host antimicrobial defense","volume":"22","author":"Murray","year":"1996","journal-title":"Intensive. Care. Med."},{"key":"10.1016\/j.cyto.2021.155637_b0375","doi-asserted-by":"crossref","unstructured":"A.L. Myasnikov, S.A. Berns, K.V. Zverev, O.A. Lartseva, P.A. Talyzin, Efficacy of Interferon Gamma in the Prevention of SARS-CoV-2 Infection (COVID-19): Results of a Prospective Controlled Trial, Int. J. Biomed. 10 (2020) 182\u2013188 (WHO COVID | ID: covidwho-805626).","DOI":"10.21103\/Article10(3)_OA1"},{"key":"10.1016\/j.cyto.2021.155637_b0380","doi-asserted-by":"crossref","unstructured":"M. Haji Abdolvahab, S. Moradi-Kalbolandi, M. Zarei, D. Bose, K. Majidzadeh-A, L. Farahmand, Potential role of interferons in treating COVID-19 patients, Int. Immunopharmacol. 90 (2021) 107171. http:\/\/dx.doi.10.1016\/j.intimp.2020.107171.","DOI":"10.1016\/j.intimp.2020.107171"},{"key":"10.1016\/j.cyto.2021.155637_b0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.36233\/0507-4088-24","article-title":"Interferon gamma in the treatment of patients with moderate COVID-19","volume":"66","author":"Myasnikov","year":"2021","journal-title":"Vopr. Virusol"},{"key":"10.1016\/j.cyto.2021.155637_b0390","article-title":"IFN-\u03b3 as a Major Antiviral Therapeutic for Viral Epidemics, Including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Clinically Forgotten but Potential Antiviral Cytokine and Non-Virus-Specific Antiviral as a New Antiviral Strategy","volume":"5","author":"Noh","year":"2020","journal-title":"J. Clin. Rev. Case Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:01:47Z","timestamp":1760907707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":78,"alternative-id":["S1043466621002234"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155637","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Between immunomodulation and immunotolerance: The role of IFN\u03b3 in SARS-CoV-2 disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155637"}}